30th Jun 2008 15:00
|
For Immediate Release |
30 June 2008 |
ImmuPharma PLC
Annual Report and Accounts
In accordance with Rule 20 of the AIM Rules, ImmuPharma PLC (AIM:IMM), the specialist drug discovery and development company, confirms that the Annual Report and Accounts for the year ended 31 December 2007, has been posted to shareholders.
The annual report is available, in electronic form, for download on the Company's website www.immupharma.com.
For further information please contact:
|
ImmuPharma PLC: |
|
|
Dimitri Dimitriou, Chief Executive Officer |
+44 20 7152 4080 |
|
Richard Warr, Chairman |
+44 20 7152 4080 |
|
Buchanan Communications |
+ 44 20 7466 5000 |
|
Lisa Baderoon |
|
|
Rebecca Skye Dietrich |
|
|
Panmure Gordon & Co |
|
|
Andrew Burnett |
+44 151 243 0963 |
Related Shares:
Immupharma